| TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID |
Globe Newswire |
09/11 |
07:00 |
| Pharmazz Inc. announces that Dr. Neil Marwah has joined the Company as its President |
Globe Newswire |
09/11 |
07:00 |
| Nxera Pharma’s Partner Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers |
Globe Newswire |
09/11 |
06:52 |
| Dental Biomaterials Market Size and Share Projected to Surpass USD 13.0 Billion by 2031 at 6.8% CAGR - Report by Transparency Market Research, Inc. |
Globe Newswire |
09/11 |
06:44 |
| CAE LAWSUIT NEWS: A Class Action Lawsuit has been Filed Against CAE Inc. for Securities Fraud; Contact BFA Law before September 16 Legal Deadline (NYSE:CAE) |
Globe Newswire |
09/11 |
06:32 |
| KUKE Music Successfully Develops "KUKE Music for Cars" Version, Aims to Complete Testing by End of September |
Globe Newswire |
09/11 |
06:30 |
| Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC |
Globe Newswire |
09/11 |
06:30 |
| The Atrisco Solar & Storage Project Has Commenced Commercial Operations |
Globe Newswire |
09/11 |
06:01 |
| Celiac Disease Diagnostics Market to Reach US$ 1.42 Billion by 2034, Driven by 8.5% CAGR | Fact.MR Report |
Globe Newswire |
09/11 |
06:00 |
| Big Data Analytics Market to Reach $1.1 Trillion, Globally, by 2032 at 14.5% CAGR: Allied Market Research |
Globe Newswire |
09/11 |
05:38 |
| IGI Announces Publication in Nature Cancer on ISB 2001, IGI's Innovative Trispecific Antibody for Relapsed/Refractory Multiple Myeloma |
Globe Newswire |
09/11 |
05:00 |
| SOLASTA Bio Completes $14m Series A to Accelerate Nature-Inspired Crop Protection |
Globe Newswire |
09/11 |
04:51 |
| Oxford-Harrington Rare Disease Centre Appoints Influential UK Leader in Health Innovation Policy, Baroness Nicola Blackwood, to its Advisory Council |
Globe Newswire |
09/11 |
04:00 |
| OKX Ventures Partner Jeff Ren Moderates Panel on APAC's Investment Potential at Aptos Experience |
Globe Newswire |
09/11 |
04:00 |
| LinkGevity Secures Place in Prestigious SPACE-H Accelerator Program |
Globe Newswire |
09/11 |
04:00 |
| Press Release: Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU |
Globe Newswire |
09/11 |
01:05 |
| Dupixent® (dupilumab) Phase 3 Trial Confirms Significant Improvements in Itch and Hives for Patients with Chronic Spontaneous Urticaria (CSU) |
Globe Newswire |
09/11 |
01:04 |
| Bioversys Announces Strategic Investment From GIBF2 and Launch of BV100 Clinical Program in China |
Globe Newswire |
09/11 |
01:00 |
| Press Release: Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivotal study |
Globe Newswire |
09/11 |
01:00 |
| James Earl Jones’ Darth Vader voice lives on through AI. Voice actors see promise and peril in that |
AP Online |
09/11 |
00:59 |
| Dupixent® (dupilumab) Is the First and Only Biologic to Achieve Significant Improvements in Disease Remission and Symptoms in Bullous Pemphigoid (BP) Positive Pivotal Trial |
Globe Newswire |
09/11 |
00:59 |
| OKX Ventures Invests in Nytro Lab's Castile; Beta Test for AAA Web 3 RPG Launched on September 10 |
Globe Newswire |
09/10 |
23:15 |
| OKX is TOKEN2049 Singapore Title Sponsor for Third Straight Year |
Globe Newswire |
09/10 |
23:00 |
| Francine becomes a hurricane as Louisiana residents brace for expected Wednesday landfall |
AP Online |
09/10 |
22:55 |
| DXC TECHNOLOGY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against DXC Technology Company - DXC |
Globe Newswire |
09/10 |
22:48 |
